Albemarle stock: buy or sell?
February 21st, 2020
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents for applications in lithium batteries, high performance greases, thermoplastic elastomers for car tires, rubber soles and plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications.
Should I buy Albemarle stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Albemarle stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Albemarle stock a buy?
Banks and financial institutions publish stock ratings everyday.Unfortunately, we couldn't detect any rating for ALB stock for the last 30 days.
Albemarle stock analysis
After boosting an astounding 5.27% yesterday, Albemarle closed today at $92.43 and eased a fateful -1.99%.
After boosting an astounding 5.27% yesterday, Albemarle closed today at $92.43 and eased a fateful -1.99%. Since January 31st when SMA100d and SMA200d crossed up, ALB price gained $11.65 per share (14.42%). Since price and SMA200d lines crossed up on December, ALB climbed $22.98 (33.09%). From a daily perspective, ALB is in a short term uptrend after plotting its last bottom ($82.10, on February/7) higher than the previous bottom, and its last top ($99.40, yesterday) also over the previous top. Now trading in between its last bottom and last top ALB might consolidate in a plain range, waiting to break out over $99.40 or down under $82.10.
After boosting an outstanding 7.92% in a week last week, Albemarle closed this week at $92.43 and soared a remarkable 3.11%. With this, it's been 3 green weeks in a row, gaining $12.15 or 14.97%.
In a weekly time frame, Albemarle stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, ALB might consolidate in a flat-base, waiting to break out over or down under . Since late January when SMA20w and SMA40w crossed up, ALB price gained $11.53 per share (14.25%). Since price and SMA40w lines crossed up by mid December 2019, ALB climbed $25.80 (38.72%).
Albemarle stock price history
Albemarle stock went public on February 22nd, 1994 with a price of $3.701. Since then, ALB stock grew a 2,398.10%, with an average of 95.90% per year. If you had invested right after ALB's IPO a $1,000 in Albemarle stock in 1994, it would worth $23,981.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Albemarle stock historical price chart
ALB stock reached 52-week highs yesterday at $99.40, and all-time highs 2017-11-08 with a price of 139.76.
Albemarle stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' ALB stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price target for Albemarle stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAlbemarle presented slightly fine results for 2018-Q4 . Albemarle inched Earnings per Share (EPS) by 4.80%, beating experts consensus of $1.46. Albemarle posted $1.53.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a cool growth of 9.86% to $3,374.95 M USD. When comparing 2018 vs 2017, similarly, profit margin (that is, the net income divided by revenues) boosted a 18.76% to 20.55%.
|2013||$2,620 M||-||$413 M15.8%||-|
|2014||$2,446 M||-6.66%||$133 M5.5%||-67.73%|
|2015||$3,651 M||49.31%||$335 M9.2%||151.21%|
|2016||$2,677 M||-26.68%||$644 M24.0%||92.20%|
|2017||$3,072 M||14.75%||$55 M1.8%||-91.48%|
|2018||$3,375 M||9.86%||$694 M20.6%||1,164.47%|
Quarterly financial resultsAlbemarle posted $921.70 million in revenues for 2018-Q4, a 18.51% improvement compared to previous quarter. Reported quarter income marked $129.60 million with a profit margin of 14.06%. Profit margin depreciated a -2.62% compared to previous quarter when profit margin was 16.68%. When comparing revenues to same quarter last year, Albemarle sales marked a great increase and escalated a 7.45%.
|2017-Q1||$722 M||-||$51 M7.1%||-|
|2017-Q2||$737 M||2.11%||$103 M14.0%||101.78%|
|2017-Q3||$755 M||2.39%||$119 M15.7%||14.85%|
|2017-Q4||$858 M||13.63%||$-218 M-25.5%||-284.01%|
|2018-Q1||$822 M||-4.22%||$132 M16.0%||-160.34%|
|2018-Q2||$854 M||3.92%||$302 M35.4%||129.55%|
|2018-Q3||$778 M||-8.92%||$130 M16.7%||-57.10%|
|2018-Q4||$922 M||18.51%||$130 M14.1%||-0.11%|
Albemarle ownershipWhen you are planning to buy shares of a company, it's worth to overview its ownership structure.
Albemarle shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.70% of all shares.
Bearish positions for ALB stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Albemarle:
|Market cap||$9.8 B|
|Total shares||106.0 M|
|Float shares||105.5 M|
|- Institutional holdings (%)||94.5%|
|- Insider holdings (%)||0.7%|
|Shares in short selling||0.0%|
|Friday, February 21st, 2020|
|Day range||$90.46 - $93.32|
|Average true range||$4.19|
|50d mov avg||$77.89|
|100d mov avg||$71.74|
|200d mov avg||$69.70|
Albemarle performanceTo measure stock performance is always good to compare with competitors or related stocks. We picked as the bechmarking frame for Albemarle stock.
Albemarle competitorsUnfortunately, we could not find any public company that could be defined as Albemarle competitor. This doesn't mean Albemarle does not have any competitor in the market, it's just we could not detected it.
Latest Albemarle stock news
- Seeking AlphaLithium Stocks When The Sentiment Is Negative - AlbemarleJuly 25, 2019
- Seeking AlphaPiedmont Lithium Making Progress In Albemarle's And Livent's BackyardJuly 5, 2019
- Seeking AlphaAlbemarle - More Than Just LithiumJune 20, 2019
- Seeking AlphaAlbemarle: Unique Total Return Opportunity For The Patient InvestorJune 12, 2019
- Seeking AlphaAlbemarle: Strong Lithium Growth Potential Lies AheadJune 3, 2019